Comparison of Diagnostic Efficacy of Dual-energy CT and Ultrasound in Gouty Arthritis
Overview
Affiliations
Objective: To explore the performance and effect of dual-energy computed tomography (CT) and ultrasound in the diagnosis of gouty arthritis and to provide a reference for the clinical diagnosis of gouty arthritis.
Methods: A retrospective analysis of 76 patients with gouty arthritis admitted to the hospital from June 2020 to June 2022 was conducted. Patients were diagnosed with gouty arthritis using ultrasound and dual-energy CT technology. The accuracy of diagnosis by different imaging techniques was analyzed along with the imaging findings of ultrasound and dual-energy CT.
Results: Seventy-six patients, 60 men and 16 women, ranging in age from 20 to 77 years (mean age 50.8 ± 10.92 years), presented with uric acid levels of 254.1-720.05 μmol/L (mean 482.17 ± 105.06 μmol/L) and C-reactive protein levels ranging from 4.25 to 10.3 mg/L. The receiver operating characteristic curve showed that the area under the curve and specificity of serum uric acid were higher by dual-energy CT than those of ultrasound in the diagnosis of gouty arthritis. The dual-energy CT detection rate of tophi was significantly higher than the ultrasound detection rate (p < .05). For inflammatory effusion and synovial thickening, the ultrasound detection rates were significantly higher than the dual-energy CT detection rates (p < .05). Regarding soft-tissue edema, the detection rate of the two methods was not significantly different (p > .05).
Conclusion: Compared with ultrasound, dual-energy CT has increased accuracy in the diagnosis of gouty arthritis.
Zhang P, Li D, Li D Clin Exp Med. 2025; 25(1):56.
PMID: 39937265 PMC: 11821689. DOI: 10.1007/s10238-025-01568-4.
Study on risk factor analysis and model prediction of hyperuricemia in different populations.
Hou K, Shi Z, Ge X, Song X, Yu C, Su Z Front Nutr. 2024; 11:1417209.
PMID: 39469332 PMC: 11513274. DOI: 10.3389/fnut.2024.1417209.
Wang Q, Chen B, Zhang Z, Tang X, Li Y Heliyon. 2024; 10(11):e31888.
PMID: 38841465 PMC: 11152737. DOI: 10.1016/j.heliyon.2024.e31888.